510(k) K211181
K211181 is an FDA 510(k) premarket notification submitted by Biocartis NV for the device "Idylla MSI Test". The FDA issued a decision of Substantially Equivalent on Feb 27, 2023. The device falls under product code PZJ (Lynch Syndrome Test System), a Class II device regulated under 21 CFR 864.1866.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 27, 2023
- Date Received
- Apr 20, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Lynch Syndrome Test System
- Device Class
- Class II
- Regulation Number
- 864.1866
- Review Panel
- PA
- Submission Type
- 510(k)
The Lynch syndrome test system is used to identify loss of DNA mismatch repair proteins or microsatellite instability in tumor tissue from cancer patients for the purpose of identifying patients who may benefit from additional testing for the inherited cancer predisposition Lynch Syndrome
Need the full FDA record for Biocartis NV? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.